Brief: Ocumension Therapeutics Says Group And Alcon Enter Transaction
12/08/2024 16:33
Aug 12 (Reuters) - Ocumension Therapeutics 1477.HK :
* GROUP AND ALCON ENTER INTO TRANSACTION
* OCUMENSION HK AGREED TO ACQUIRE FROM ALCON RESEARCH
* OCUMENSION HK TO ACQUIRE TRANSFERRED ASSETS FOR
MANUFACTURE AND
COMMERCIALIZATION OF TRANSFERRED PRODUCTS IN TERRITORY
Further company coverage: 1477.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application